Shanghai No1 Pharmacy Co Ltd (SHG:600833) — Market Cap & Net Worth

$340.81 Million USD  · CN¥2.33 Billion CNY  · Rank #14340

Market Cap & Net Worth: Shanghai No1 Pharmacy Co Ltd (600833)

Shanghai No1 Pharmacy Co Ltd (SHG:600833) has a market capitalization of $340.81 Million (CN¥2.33 Billion) as of September 21, 2026. Listed on the SHG stock exchange, this China-based company holds position #14340 globally and #4287 in its home market, demonstrating a -1.04% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai No1 Pharmacy Co Ltd's stock price CN¥10.44 by its total outstanding shares 223086347 (223.09 Million). Also see 600833 total asset value for a full breakdown of the balance sheet.

Shanghai No1 Pharmacy Co Ltd Market Cap History: 2015 to 2026

Shanghai No1 Pharmacy Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $621.03 Million to $340.81 Million (-4.87% CAGR). Also see Shanghai No1 Pharmacy Co Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.

Shanghai No1 Pharmacy Co Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Shanghai No1 Pharmacy Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 600833 live share price for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.20x

Shanghai No1 Pharmacy Co Ltd's market cap is 0.20 times its annual revenue

Industry average: 0.19x Higher than industry average

Latest Price to Earnings (P/E) Ratio

7.31x

Shanghai No1 Pharmacy Co Ltd's market cap is 7.31 times its annual earnings

Industry average: 1.94x Higher than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2016 $635.12 Million $1.52 Billion $46.03 Million 0.42x 13.80x
2017 $431.35 Million $1.56 Billion $43.48 Million 0.28x 9.92x
2018 $285.04 Million $1.18 Billion $47.19 Million 0.24x 6.04x
2019 $295.77 Million $1.24 Billion $53.09 Million 0.24x 5.57x
2020 $307.65 Million $1.59 Billion $68.54 Million 0.19x 4.49x
2021 $298.96 Million $1.40 Billion $49.42 Million 0.21x 6.05x
2022 $363.27 Million $2.66 Billion $143.56 Million 0.14x 2.53x
2023 $392.39 Million $1.82 Billion $89.28 Million 0.22x 4.40x
2024 $440.70 Million $1.92 Billion $163.06 Million 0.23x 2.70x
2025 $422.09 Million $2.13 Billion $57.75 Million 0.20x 7.31x

Competitor Companies of 600833 by Market Capitalization

Companies near Shanghai No1 Pharmacy Co Ltd in the global market cap rankings as of September 21, 2026. Review Shanghai No1 Pharmacy Co Ltd tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Shanghai No1 Pharmacy Co Ltd by market ranking:

  • JD HEALTH INTL LTD (F:8ZN): Ranked #1949 globally with a market cap of $12.04 Billion USD ( €10.30 Billion EUR).
  • Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2185 globally with a market cap of $10.37 Billion USD.
  • ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2555 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
  • Raia Drogasil S.A (SA:RADL3): Ranked #2916 globally with a market cap of $6.94 Billion USD ( R$35.37 Billion BRL).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#1949 JD HEALTH INTL LTD F:8ZN $12.04 Billion €3.94
#2185 Walgreens Boots Alliance Inc NASDAQ:WBA $10.37 Billion $11.98
#2555 ALIB.HL.INF.TEC.UNSP.ADR F:TWYA $8.42 Billion €8.95
#2916 Raia Drogasil S.A SA:RADL3 $6.94 Billion R$20.23

Shanghai No1 Pharmacy Co Ltd Historical Marketcap From 2015 to 2026

Between 2015 and today, Shanghai No1 Pharmacy Co Ltd's market cap moved from $621.03 Million to $ 340.81 Million, with a yearly change of -4.87%.

Year Market Cap Change (%)
2026 CN¥340.81 Million -19.26%
2025 CN¥422.09 Million -4.22%
2024 CN¥440.70 Million +12.31%
2023 CN¥392.39 Million +8.02%
2022 CN¥363.27 Million +21.51%
2021 CN¥298.96 Million -2.83%
2020 CN¥307.65 Million +4.02%
2019 CN¥295.77 Million +3.76%
2018 CN¥285.04 Million -33.92%
2017 CN¥431.35 Million -32.08%
2016 CN¥635.12 Million +2.27%
2015 CN¥621.03 Million --

End of Day Market Cap According to Different Sources

On Sep 21st, 2026 the market cap of Shanghai No1 Pharmacy Co Ltd was reported to be:

Source Market Cap
Yahoo Finance $340.81 Million USD
MoneyControl $340.81 Million USD
MarketWatch $340.81 Million USD
marketcap.company $340.81 Million USD
Reuters $340.81 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Shanghai No1 Pharmacy Co Ltd

SHG:600833 China Pharmaceutical Retailers
Market Cap
$340.81 Million
CN¥2.33 Billion CNY
Market Cap Rank
#14340 Global
#4287 in China
Share Price
CN¥10.44
Change (1 day)
+2.25%
52-Week Range
CN¥9.02 - CN¥14.98
All Time High
CN¥21.88
About

Shanghai No.1 Pharmacy Co.,Ltd., together with its subsidiaries, engages in the retail and wholesale of pharmaceutical products in China. It sells food, medical equipment, health convenience products, and other commodities. The company serves medical institutions, pharmacies, commodity distribution companies, and franchise stores. Shanghai No. 1 Pharmacy Co.,Ltd. was founded in 1992 and is headqu… Read more